Viread, Truvada listed in green list

Published: 2013-01-31 06:57:00

Updated: 2013-01-31 06:57:00

Several new drugs were recently listed in Korea’s green list which can be compared to the "Orange Book" in the USA, according to Yakup.com, a pharmaceutical information provider.

The data showed that new medicines registered into the list in January include Gilead Sciences’ Viread/Truvada, Boe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK